• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Efficiency of remote monitoring and guidance in blood pressure management

byPaary BalakumarandAlex Chan
August 13, 2025
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Remote monitoring significantly reduced systolic blood pressure (BP) compared to usual care (−2.7 mm Hg, p = 0.002), especially in patients with uncontrolled baseline BP who achieved a 17.7 mm Hg systolic BP reduction.

2. Self-monitoring alone did not improve BP control versus usual care

Evidence Rating Level: 1 (Excellent) 

Hypertension management remains a critical challenge, with traditional methods like office-based monitoring and self-monitoring showing limitations in long-term efficacy. This multicenter randomized controlled trial compared the effectiveness of remote monitoring, self-monitoring, and usual care in 1,006 hypertensive patients over 24 months. Participants were assigned to one of three groups: remote monitoring (using a cloud-based system with physician alerts for abnormal readings), self-monitoring (manual logging without remote feedback), or usual care (routine clinical management). The primary outcome was systolic blood pressure (BP) reduction. Results demonstrated that the remote monitoring group achieved significantly greater systolic BP reductions (−2.7 mm Hg vs. usual care, p = 0.002) and higher target BP attainment rates (69.65% at 24 months). Notably, patients with suboptimal baseline BP in the remote group saw a 17.7 mm Hg drop in systolic BP. Self-monitoring alone showed no significant benefit over usual care. The remote group also exhibited increased use of calcium channel blockers, diuretics, and combination therapy, suggesting better medication optimization. The study concludes that remote monitoring with real-time clinician feedback enhances BP control, while self-monitoring without additional support is ineffective.

Click to read the study in BMC Medicine

Image: PD

RELATED REPORTS

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

2 Minute Medicine Rewind

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: blood pressurecardiologyfamily medicinehypertension
Previous Post

#VisualAbstract: Mass Administration of Ivermectin Reduces Transmission of Malaria in Kwale County, Kenya

Next Post

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Oral GLP 1 reshapes obesity visits, deepfake doctors fuel DIY injectables, home longevity scales overwhelm clinics, and TV CPR scripts leave bystanders unprepared

January 26, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

January 12, 2026
Placebo formulation impacts effectiveness of pain control in osteoarthritis
Health

Infrapatellar fat pad glucocorticoid injections may not reduce pain or effusion volume in patients with knee osteoarthritis

January 12, 2026
Next Post
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

Radiation plus hormone therapy may improve prostate cancer survival

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind February 9, 2026
  • An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
  • Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.